Clinical Trials in Pittsburgh

Showing 6701-6720 of 21,047 trials

[C-11]PiB PET Imaging in Alcohol Use Disorders

NCT03746366

To determine whether alcoholics (AUD) have a greater rate of amyloid positivity (ABeta+) compared to an age-matched cognitively normal control group (HC).

Alcohol Use Disorder

University of Pittsburgh39 participantsStarted Dec 2018

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 182 miles

A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

NCT03817424

The purpose of this study is to evaluate the safety and tolerability of escalating, multiple subcutaneous (SC) doses of VIB7734 in participants with Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis.

Systemic Lupus ErythematosusCutaneous Lupus ErythematosusSjogren's Syndrome+3 more

Amgen31 participantsStarted Dec 2018

Anniston, Alabama, United States • Birmingham, Alabama, United States • Los Angeles, California, United States +27 more locations

[C-11]PiB PET Imaging in Alcohol Use Disorders

A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Find Trials by Condition in Pittsburgh

Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124

A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia

Risk of Recurrent CeAD After Pregnancy

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants

Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells

Study of ATH434 in Participants with Multiple System Atrophy

Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Postpartum Intervention for Mothers With Opioid Use Disorders

Embecta AID System in Adults With Type 2 Diabetes

An Age-Stratified Data Collection Study to Establish a Normative Database Using the 3D Optical Coherence Tomography 3D OCT-1000 Mark II

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.

Nitrous Oxide for the Treatment of Major Depressive Disorder